Format

Send to

Choose Destination
Eur J Pharmacol. 2016 Nov 5;790:83-91. doi: 10.1016/j.ejphar.2016.06.058. Epub 2016 Jul 1.

Extracellular vesicles in renal tissue damage and regeneration.

Author information

1
Department of Biotechnology and Health Sciences, Molecular Biotechnology Center; University of Turin, Italy.
2
Department of Biotechnology and Health Sciences, Molecular Biotechnology Center; University of Turin, Italy. Electronic address: benedetta.bussolati@unito.it.

Abstract

Extracellular vesicles (EVs) appear as important actors in cell-to-cell communication. EV content is characterized by proteins and RNA species that dynamically reflect cell and tissue state. Urinary EVs in particular may act in inter-nephron communication with possible beneficial or detrimental effects. Increasing interest is addressed to the pharmacological properties of EVs as a cell-free therapy, since several of the effects crAQ/tgqcedited to stem cells have been recapitulated by administration of their EVs. Preclinical data in models of renal damage indicate a general regenerative potential of EVs derived from mesenchymal stromal cells of different sources, including bone marrow, fetal tissues, urine and kidney. In this review we will discuss the results on the effect of EVs in repair of acute and chronic renal injury, and the mechanisms involved. In addition, we will analyse the strategies for EV pharmacological applications in renal regenerative medicine and limits and benefits involved.

KEYWORDS:

Acute kidney injury; Cell-free therapy; Exosomes; Mesenchymal stem cells; MicroRNA

PMID:
27375075
DOI:
10.1016/j.ejphar.2016.06.058
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center